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Abstract
Essential tremor (ET) is a complex genetic disorder for which no causative gene has been found. Recently, a genome-wide
association study reported that two variants in the LINGO1 locus were associated to this disease. The aim of the present
study was to test if this specific association could be replicated using a French-Canadian cohort of 259 ET patients and 479
ethnically matched controls. Our genotyping results lead us to conclude that no association exists between the key variant
rs9652490 and ET (Pcorr=1.00).
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Introduction
Essential tremor (ET), with an estimated prevalence around 5%
in persons aged over 65 years, is the most common movement
disorder of adults [1]. Although segregation analysis of ET in
families strongly supports the contribution of genetic factors [1],
genomewide linkage studies have failed to identify ET-susceptibility
genes.Thislackofsuccessmaybeattributabletoa complexmode of
inheritance involving environmental factors and multiple low-
penetrance susceptibility alleles [2]. Recently, a genome-wide
association study (GWAS) was conducted by Stefansson et al. using
452ETcasesand 14,394controlsfromtheIcelandicpopulation[3].
They found two single nucleotide polymorphisms (SNP) that were
associated with ET (rs9652490 and rs11856808), both in intron 3 of
the leucine-rich repeat neuronal 6A (GenBank: BC068558.1
LINGO1) gene. The aim of the present study was to attempt to
replicate these findings in another population.
Results
A total of 738 individuals from the province of Que ´bec, Canada
were genotyped for rs9652490 and rs11856808. Genotyping
success rate was above 98% and both SNPs were in Hardy-
Weinberg equilibrium. Minor allele frequencies (MAF) from our
control group were consistent with the MAF reported in the
GWAS report [3]. Neither genotype counts nor allele frequencies
differed between cases and controls (Table 1). An analysis of a
subset ET, familial cases, revealed no significant association with
the two SNPs.
Discussion
Our association study using a French-Canadian cohort of ET
cases does not support an association between rs9652490 or
rs11856808 and the disease. Moreover this lack of association is
also true when only the subset of patients with a familial history of
ET is examined, contrarily to other studies discussed below. It is
noteworthy that the size of our cohort is comparable to the size of
cohorts used by other groups who also tested if the association with
rs9652490 could be replicated.
Our power to detect an association of low impact is limited
because of the sample size available. Therefore, the lowest odds
ratio (OR) we could ascertain from it is 1.54. Other replication
studies published had lower ORs (1.33, 1.28) but when looking at
their results closely, the 95% confidence interval included 1.00.
Because this means there is no relationship between the parameter
tested and the disease, we chose not to base our power calculations
on these ORs (see Materials and Methods section).
To have an 80% power to detect an effect of the rs9652490
variant in the French-Canadian population with the current
relative risk observed, it would require around 40,000 cases with
the same control to case ratio [4]. This is highly indicative of how
low the effect of the variant is on the genetics of ET in the French-
Canadian population.
The few studies that have also attempted to replicate the results
of the original report are the following [3,5,6,7,8,9,10]: One where
ET cases from both Germany and France were used where a
significant association was found between the G allele of
rs9652490 and ET in the German cohort; a result they replicated
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The same study also conducted a separate analysis of familial ET
cases versus the controls and observed a stronger signal. A second
study by Tan et al. investigated case-control series of ET from
Singapore and a significant association between the G allele and
the phenotype was found only in a subset of patients with familial
history of ET (P=0.007 OR=1.69); when using the entire cohort
they found a non-significant but suggestive association between G
allele of rs9652490 and ET (P=0.068) [6]. In a third study
conducted using a non-hispanic North-American cohort of ET
patients the association between ET and rs9652490 was also
marginal (P=0.0569 OR=1.33 [0.99–1.80]) [7]. Altogether these
three studies supported, to a certain extent, the trend observed in
the original paper suggesting that the G allele was associated with
ET.
Conversely two different studies investigated the association
with rs9652490 using North-American ET and PD patients [8,9].
The ET cohort investigated in both studies consisted of 349 and
353 patients, respectively. The two studies were conducted by the
same group, therefore we will discuss the results of the first report
only: the A allele of rs9652490 was the risk allele for both disorders
(P=0.0145 OR=2.2), compared to the G allele reported. It is
unlikely that these conflicting results are due to population-specific
susceptibility variants as the follow-up group used in the original
report to validate the association between the G allele of
rs9652490 and ET included individuals from the United States
and Europe [3]. This variability might by due to the ‘‘flip-flop’’
phenomenon, which occurs, in complex traits, when the associated
allele is in weak linkage disequilibrium (LD) with the true causal
variant. Even if the samples are from the same origin,
environmental factors might contribute to the association with
the other allele [11].
The last study was conducted using Chinese ET and PD cohorts
and no association was found between neither ET, or PD, and
LINGO1 (P=0.910 OR=1.022 [0.706–1.477]) [10]. However,
this negative study probably does not result from population
differences, as Tan et al. had failed to observe any differences in
linkage disequilibrium of markers around rs9652490 between
Asians and Caucasians [6].
Even if we know that the French-Canadian population is quite
homogeneous, we did not test LD between the North-American
population (from the United States and Canada), the French
population and French-Canadian one. Although we cannot
exclude a difference in LD between the French-Canadian
population and other ones, if rs9652490 is a marker in LD of
the true causal variant, which is the hypothesis prevailing in this
case, [5,7,8] we would have seen an association with either the G
allele or the A allele, as reported by other groups. Moreover, for
complex traits a possible ‘‘synthetic association’’ may be seen. The
concept of such an association relies on the association seen
between a common variant and rare causal ones [12]. In synthetic
association, it was shown that true causal variants were not
necessarily in the same LD block as the common associated SNP.
Therefore, even if we did not test LD in LINGO1 in the French-
Canadian population, a true association could have been revealed
if there was a suggested one.
The aim of this report was solely to replicate the findings of the
first GWAS describing an association in ET patients, using
French-Canadian ET patients, and so no direct sequencing or
genotyping of additional SNPs was done for the whole LINGO1
gene. Such broader experiments could be done in a near future to
see if another association between LINGO1 and ET could be
identified in the French-Canadian population.
Meta-analyses were recently reported by Tan et al., Clark et al.
and Vilarin ˜o et al. and so even if our results are revealing about
lack of association in the French-Canadian population, a new
meta-analysis with only these new French-Canadian cases would
not be significantly different yet [6,7,8]; more replication studies
would be needed before such a meta-analysis is needed.
In conclusion, our data, which does not support an association
between rs9652490 or rs11856808 and ET in French-Canadians,
and parallel replication studies, argue against a definitive role for
these LINGO1 polymorphisms in ET. Furthermore it is important
to keep in mind that even if rs9652490 showed the highest
association signal in the original report, none of the markers
genuinely reached a genomewide significance level in this study
(P=3.0610
27 and 1.6610
27 was expected) [3]. A GWAS using a
much larger sample size would be needed to assess whether
common genetic variants predispose to ET.
Table 1. Genotype and allelic distribution of rs9652490 and rs11856808 among ET cases (n=259) and controls (n=479).
SNP HWE Genotype/Allele Patients N (%) Controls N (%) *P-values ( Corrected)
rs9652490 A/A 153(59) 287(61)
A/G 94(37) 160(34)
G/G 10(4) 23(5) 0.91 (1.00)
0.75 MAF All (G) 0.22 0.22 0.95 (1.00)
1.00 MAF FET (G) 0.23 0.22 0.71 (1.00)
rs11856808 C/C 117(46) 204(43)
C/T 105(42) 204(43)
T/T 29(12) 63(14) 0.34 (0.68)
0.24 MAF All (T) 0.32 0.35 0.35 (0.70)
0.23 MAF FET (T) 0.34 0.35 0.81 (1.00)
*Cochrane-Armitage trend test for genotype comparisons and Fisher’s exact test for allele comparisons.
Correction for multiple testing using Bonferroni’s correction.
HWE. Hardy-Weinberg equilibrium exact test.
MAF. Minor allele frequency.
FET. Familial Essential Tremor.
doi:10.1371/journal.pone.0016254.t001
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Ethics Statement
The local institutional committee, Comite ´s d’e ´valuation scien-
tifique et d’e ´thique de la recherche of Centre hospitalier de
l’Universite ´ de Montre ´al (CHUM) approved of this project:
Identification of the Gene Predisposing to Tremor, following the
Declaration of Helsinki. Informed written consent was obtained
from each participant.
Subjects
A total of 259 patients with ET (104 with familial history of ET)
and 479 ethnically-matched population controls were included in
this study. All individuals were recruited in the province of
Quebec, Canada, and probands were ascertained by neurologists
specialized in movement disorders. Informed written consent was
obtained from each participant and the study was approved by the
local institutional ethic committees.
Genotyping
Markers rs9652490 and rs11856808 were genotyped by Taq-
Man SNP Genotyping Assay following the manufacturer’s
instructions and results were assessed using the Applied Biosystems
7900 Fast Real-Time PCR System and SDS software (vs. 2.2.2) for
allele calling.
Statistical analyses
The Hardy-Weinberg equilibrium exact test was performed to
ascertain the normal heterogeneity of the population for the two
markers tested. Case-control association study was performed
using the Cochran-Armitage and the Fisher’s exact tests.
Correction for multiple comparisons testing was made using
Bonferroni’s algorithm as the two SNPs tested were in LD. All
these tests were done using PLINK software [13] (vs.1.07). Power
to detect association was determined using the Genetic Power
Calculator and, if the effect of the variant was as strong as the
effect seen in the Icelandic population (OR of the G allele: 1.63),
this cohort would be of sufficient size to get an 88% power of
detection [4].
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